About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

ChIP-Seq (H3K9me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, as part of the International Human Epigenome Consortium.

ChIP-Seq (H3K9me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000552 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF00000586047 bam 6.9 GB Report
EGAF00000586054 bam 7.7 GB Report
EGAF00000586061 bam 4.9 GB Report
EGAF00000586068 bam 4.6 GB Report
EGAF00000586075 bam 3.8 GB Report
EGAF00000586082 bam 4.2 GB Report
EGAF00000586089 bam 4.7 GB Report
EGAF00000586096 bam 5.2 GB Report
EGAF00000586103 bam 4.5 GB Report
EGAF00000586110 bam 7.3 GB Report
EGAF00000733002 bam 6.2 GB Report
EGAF00000733021 bam 7.2 GB Report
EGAF00000733056 bam 6.1 GB Report
EGAF00000733059 bam 6.0 GB Report
EGAF00000733066 bam 8.3 GB Report
EGAF00000835469 bam 5.8 GB Report
EGAF00000835482 bam 6.7 GB Report
EGAF00000835492 bam 9.3 GB Report
EGAF00000861600 bam 6.1 GB Report
EGAF00000861601 bam 8.1 GB Report
EGAF00000864339 bam 7.2 GB Report
EGAF00000864347 bam 6.4 GB Report
EGAF00000864350 bam 5.0 GB Report
EGAF00000864359 bam 4.0 GB Report
EGAF00000864361 bam 4.6 GB Report
EGAF00000864371 bam 4.2 GB Report
EGAF00000864383 bam 4.5 GB Report
EGAF00000864386 bam 3.7 GB Report
EGAF00000864389 bam 4.4 GB Report
EGAF00000864397 bam 5.2 GB Report
EGAF00000887879 bam 4.3 GB Report
EGAF00000887892 bam 9.4 GB Report
EGAF00000887895 bam 4.3 GB Report
EGAF00000887897 bam 5.6 GB Report
EGAF00000887910 bam 6.5 GB Report
EGAF00000887913 bam 7.7 GB Report
EGAF00000887925 bam 6.2 GB Report
EGAF00000887928 bam 9.0 GB Report
EGAF00000887934 bam 6.5 GB Report
EGAF00000887937 bam 8.0 GB Report
EGAF00000887946 bam 10.7 GB Report
EGAF00000887966 bam 5.7 GB Report
EGAF00000887970 bam 8.6 GB Report
EGAF00000887980 bam 10.5 GB Report
EGAF00000887985 bam 11.3 GB Report
EGAF00000887990 bam 10.5 GB Report
EGAF00000887994 bam 6.0 GB Report
EGAF00000888677 bam 8.0 GB Report
48 Files (311.6 GB)